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Leishmaniasis and Chagas disease are parasitic protozoan infections that affect the poorest population in
the world, causing high mortality and morbidity. As a result of highly toxic and long-duration treatments,
novel, safe and more efﬁcacious drugs are essential. In this work, the methanol (MeOH) extract from the
leaves of Piper malacophyllum (Piperaceae) was fractioned to afford one alkenylphenol, which was char-
acterized as 4-[(30E)-decenyl]phenol (gibbilimbol B) by spectroscopic methods. Anti-protozoan in vitro
assays demonstrated for the ﬁrst time that Leishmania (L.) infantum chagasiwas susceptible to gibbilimbol
B, with an in vitro EC50 of 23 lg/mL against axenic promastigotes and an EC50 of 22 lg/mL against intra-
cellular amastigotes. Gibbilimbol B was also tested for anti-trypanosomal activity (Trypanosoma cruzi)
and showed an EC50 value of 17 lg/mL against trypomastigotes. To evaluate the cytotoxic parameters,
this alkenylphenol was tested in vitro against NCTC cells, showing a CC50 of 59 lg/mL and absent hemo-
lytic activity at the highest concentration of 75 lg/mL. Using the ﬂuorescent probe SYTOX Green sug-
gested that the alkenylphenol disrupted the Leishmania plasma membrane upon initial incubation.
Further drug design studies aiming at derivatives could be a promising tool for the development of
new therapeutic agents for leishmaniasis and Chagas disease.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The Piperaceae family comprises 14 genera and ca. 4000 species
(Monteiro and Guimarães, 2009). Among these, Piper and Peperomiasevier OA license. 
a).are the most abundant with approximately 700 and 600 species,
respectively (Jaramillo et al., 2004). Phytochemical investigations
carried out on Piper species have revealed many bioactive
compounds such as amides, alkaloids, lignans, benzoic acids, and
chromenes (Sengupta and Ray, 1987; Ruangrungsi et al., 1992;
Wu et al., 1997; Parmar et al., 1998; Alécio et al., 1998; Navickiene
et al., 2000; Silva et al., 2002; Lago et al., 2004; Freitas et al., 2009;
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species display antileishmanial (Torres-Santos et al., 1999; Hermoso
et al., 2003; Bodiwala et al., 2007; Silva et al., 2009; Vendrametto
et al., 2010) and trypanocidal activities (Martins et al., 2003;
Ribeiro et al., 2004; Luize et al., 2006; Felippe et al., 2008; Regasini
et al., 2009; Flores et al., 2009; Mota et al., 2009; Cotinguiba et al.,
2009; Pelizzaro-Rocha et al., 2010; Batista et al., 2011). Thus,
considering the availability of Piperaceae species in Brazil, our
bioprospecting studies have been directed towards the discovery
of new antiparasitic agents in plants belonging to this family,
including Piper malacophyllum.
P. malacophyllum is a shrub commonly known as ‘‘pariparoba-
murta’’, with occurrence restricted to the Southeastern and South
regions of Brazil (Guimarães and Monteiro, 2006). Previous studies
have described that the bioactivity-guided fractionation of a leaf
extract from P. malacophyllum afforded two piperolides with anti-
fungal activity against Cladosporium sp. (Lago et al., 2005) and its
leaf essential oil showed broad spectrum antimicrobial activity,
especially antifungal (Santos et al., 2012). Additionally, another re-
port described the characterization of piperolides from a leaf ex-
tract using capillary electrophoresis (Oliveira et al., 2010). In this
study, a continuation of the P. malacophyllum investigation, the
MeOH extract from leaves was subjected to partition procedures
as well as chromatographic separation to afford 4-[(30E)-dece-
nyl]phenol (gibbilimbol B), which was characterized by spectro-
scopic analysis, mainly nuclear magnetic resonance (NMR) and
mass spectrometry (MS). This compound displayed in vitro
antileishmanial activity against the promastigotes and amastigotes
of Leishmania (L.) infantum chagasi, the etiologic agent of visceral
leishmaniasis, as well as against the trypomastigotes of
Trypanosoma cruzi, with disruption of the membrane of Leishmania
parasites.2. Material and methods
2.1. General experimental procedures
1H NMR and 13C spectra were recorded, respectively, at 200 and
50 MHz in a Bruker AC-200 spectrometer. CDCl3 (Aldrich) was used
as the solvent and tetramethylsilane (TMS, Aldrich) as the internal
standard. Chemical shifts are reported in d units (ppm) and cou-
pling constants (J) in Hz. Low resolution electronic impact mass
spectrometry (LREIMS) was performed using an HP 5990/5988A
mass spectrometer. Silica gel (Merck, 230–400 mesh) was used
for column chromatographic separation, while silica gel 60 PF254
(Merck) was used for analytical thin layer chromatography (TLC,
0.25 mm).
2.2. Plant material
Piper malacophyllum leaves were collected in the Parque Estadu-
al Intervales (Sisbio 15780-2), SP, Brazil, in November 2004 and
were identiﬁed by Dr. Elsie F. Guimarães. A voucher specimen
(K-447) has been deposited at the herbarium of Instituto de Pesqu-
isa do Jardim Botânico, Rio de Janeiro, RJ, Brazil.
2.3. Extraction and isolation
Dried and powdered leaves of P. malacophyllum (93 g) were ex-
tracted with MeOH (3  300 mL at room temperature), affording
10.5 g of a syrupy green extract after solvent removal under re-
duced pressure. This extract was resuspended using MeOH:H2O
(4:1) and subjected to Celite column chromatography eluted with
MeOH:H2O 4:1 (fractions A1 and A2), MeOH (fraction A3) and ace-
tone (fraction A4). Fraction A1 was extracted with CH2Cl2(3  200 mL), and the organic phase, after being dried using
Na2SO4, was subjected to a silica gel column chromatography
eluted with increasing amounts of ethyl acetate in n-hexane (up
to 100%) to afford six fractions (B1–B6). Fraction B6 (264 mg)
was subjected to preparative TLC eluted with n-hexane:CH2Cl2 to
give 159.8 mg of 4-[(30E)-decenyl]phenol (gibbilimbol B).
2.4. 4-[(30E)-decenyl]phenol (gibbilimbol B)
1H NMR (200 MHz, CDCl3) dH: 7.04 (d, J = 8.3 Hz, H-3/H-5), 6.75
(d, J = 8.3 Hz, H-2/H-6), 5.43 (m, H-30/H-40), 4.96 (br s, OH), 2.60 (t,
J = 7.9, H-10), 2.26 (m, H-20), 1.95 (m, H-50), 1.38–1.19 (m, H-60 to H-
90), 0.89 (t, J = 7.0 Hz, H-100). 13C NMR (50 MHz, CDCl3) dC: 153.5 (C-
1), 134.4 (C-4), 131.2 (C-40), 129.5 (C-3 and C-5), 129.3 (C-30), 115.0
(C-2 and C-6), 35.2 (C-10), 34.7 (C-20), 32.6 (C-50), 31.7 (C-80), 29.5
(C-60), 28.8 (C-70), 22.6 (C-90), 14.8 (C-100). IR (ﬁlm, cm1): 3379
(OH), 1609 (C@C), 1514 (aromatic C@C), 966 (Csp2-H opp). LREIMS
(70 eV) m/z (int. rel.): 232 (2), 108 (8), 107 (100), 91 (1), 77 (6), 55
(3), 43 (3), 41 (7).
2.5. Bioassay procedures
BALB/c mice and golden hamsters were supplied by the animal
breeding facility at the Instituto Adolfo Lutz, São Paulo, and main-
tained in sterilized cages under a controlled environment, receiv-
ing water and food ad libitum. Animal procedures were
performed with the approval of the Research Ethics Commission,
in agreement with the Guide for the Care and Use of Laboratory
Animals from the National Academy of Sciences.
2.6. Parasite maintenance
Promastigotes L. (L.) infantum chagasi (MHOM/BR/1972/LD)
were maintained in golden hamsters while the amastigotes were
obtained from the spleen by differential centrifugation at the 60–
70th day post-infection (Grecco et al., 2010). T. cruzi trypomastig-
otes (Y strain) were maintained in LLC-MK2 (ATCC CCL 7) cells
using RPMI-1640 medium supplemented with 2% calf serum at
37 C.
2.7. Mammalian cells
Peritoneal macrophages were collected from the peritoneal cav-
ity of female BALB/c mice by washing with RPMI-1640 without
phenol red, supplemented with 10% fetal bovine serum. NCTC
clone 929 cells were maintained in RPMI-1640 medium without
phenol red and supplemented with 10% fetal bovine serum at
37 C in a 5% CO2 humidiﬁed incubator.
2.8. Trypanosoma cruzi trypomastigotes
4-[(30E)-Decenyl]phenol (gibbilimbol B) was dissolved in MeOH
and diluted in RPMI-1640 medium to determine the 50% effective
concentration (EC50 value) as described above for the antileishma-
nial assay. Free trypomastigotes obtained from LLC-MK2 cultures
were counted in a Neubauer hemocytometer and seeded at
1  106/well in 96-well microplates. 4-[(30E)-Decenyl]phenol (gib-
bilimbol B) was added at the highest concentration of 150 lg/mL
for 24 h at 37 C in a 5% CO2 humidiﬁed incubator. Benznidazole
was used as the standard drug. The viability of trypomastigotes
was based on the cellular conversion of the soluble tetrazolium salt
MTT (20 lL/well) into insoluble formazan by mitochondrial en-
zymes. Formazan extraction was carried out using 10% SDS for
18 h (80 lL/well) at 24 C as described previously (Lane et al.,
1996). The number of living trypomastigotes was determined indi-
rectly by the OD at 550 nm (Grecco et al., 2010).
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Fig. 1. Chemical structure of 4-[(30E)-decenyl]phenol (gibbilimbol B).
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Leishmania spp. promastigotes
To determine the 50% effective concentration (EC50 value)
against L. (L.) infantum chagasi promastigotes, 4-[(30E)-decenyl]
phenol (gibbilimbol B) was previously dissolved in MeOH and
diluted with M-199 medium in 96-well microplates to the highest
concentration of 150 lg/mL (based on dry weight). Each compound
was tested twice at eight concentrations prepared at twofold
dilutions. Promastigotes were counted in a Neubauer hemo-
cytometer and seeded at 1  106/well with a ﬁnal volume of
150 lL. Controls with MeOH and without drugs were also per-
formed. Amphotericin B was used as a standard drug. The plate
was incubated for 24 h at 24 C and the viability of promastigotes
was veriﬁed by morphology using light microscopy and the diphe-
nyltetrazolium (MTT) assay (Tempone et al., 2009). 100% viability
was expressed based on the OD of control promastigotes, after
normalization.
2.10. Intracellular amastigotes
Peritoneal macrophages were obtained as described previously
and seeded for 24 h at 1  105/well in 16-well slide chambers
(NUNC) before infection with L. (L.) infantum chagasi amastigotes,
which were prepared at a 1:10 ratio (macrophage/amastigotes)
for 18 h at 37 C in a 5% CO2 humidiﬁed incubator. After 18 h of
incubation, infected macrophages were incubated at 37 C with
4[(3E)-dec-3-en-1-yl]phenol (gibbilimbol B) for 120 h under the
same conditions described above. Macrophages incubated without
drugs were used for control (100% infected). Glucantime was used
as a standard drug. At the end of the assay, macrophages were
ﬁxed with MeOH, stained with Giemsa and observed using a light
microscope (1000 magniﬁcation). The parasite burden was
determined by the number of infected macrophages out of 400
macrophages (Tempone et al., 2010).
2.11. Determination of the cytotoxicity against mammalian cells
NCTC-clone 929 cells were seeded at 6  104 cells/well in 96-
well microplates and incubated with gibbilimbol B and the stan-
dard drugs amphotericin B, glucantime and benznidazole for 48 h
at 37 C in a 5% CO2 humidiﬁed incubator. The viability of cells
was determined by the MTT assay as described above and the
50% cytotoxic concentration (CC50) was calculated.
2.12. Spectroﬂuorimetric detection of disruption of the Leishmania
plasma membrane
Late growth-phase (non-stationary) promastigotes of L. (L.)
infantum chagasi were washed in phosphate-buffered saline,
seeded at 2  106/well and incubated for 15 min with 1 lM SYTOX
Green (Molecular Probes) in M199 medium without phenol red,
supplemented with fetal bovine serum and hemin (Mangoni
et al., 2005). Gibbilimbol B was added at the previously determined
EC50 and ﬂuorescence was measured every 30 min for a total per-
iod of 180 min. Maximum ﬂuorescence was determined by the
addition of 0.5% Triton X-100. The control group consisted of prom-
astigotes incubated with 0.5% MeOH. Fluorescence was measured
using a microplate reader (FilterMax F5-Molecular Devices, USA)
with excitation and emission wavelengths of 485 and 520 nm,
respectively (Kulkarni et al., 2009).
2.13. Hemolytic activity
The hemolytic activity of gibbilimbol B was evaluated using
BALB/c erythrocytes. A 3% suspension of mouse erythrocytes wasincubated for 2 h with gibbilimbol B in a 96-well U-shaped micro-
plate at 25 C. The supernatant was assessed at 550 nm using a
Multiskan reader (Morais et al., 2012; Sartorelli et al., 2010).
2.14. Statistical analysis
Results are represented by the mean and standard deviation of
triplicate samples from two independent assays. The EC50 values
were calculated using sigmoid dose–response curves in Graph
Pad Prism 5.0 software, and the 95% conﬁdence intervals are in-
cluded in parentheses.3. Results and discussion
As part of a continuous search to discover new anti-protozoal
derivatives from Brazilian ﬂora (Grecco et al., 2010; Corrêa et al.,
2011; Morais et al., 2012; Grecco et al., 2012), this study reports
the isolation of one active alkenylphenol from P. malacophyllum
which was characterized by the analysis of its spectroscopic data.
Analysis of the 1H, 13C, DEPT 135, and DQF-COSY NMR spectra
along with comparison of spectroscopic data reported in the liter-
ature (Orjala et al., 1998) allowed the identiﬁcation of the isolated
compound as 4-[(30E)-decenyl]phenol (gibbilimbol B) (Fig. 1).
Gibbilimbol B was tested in vitro against the visceral species of
Leishmania (L. (L.) infantum chagasi). According to the lack of mito-
chondrial oxidation (MTT assay), this compound showed a leish-
manicidal activity against promastigotes, with an EC50 of
23.32 lg/mL (Table 1). Amphotericin B was used as the standard
and was about 167-fold more effective than the tested compound
(EC50 of 0.137 lg/mL). Although gibbilimbol was less effective than
amphotericin B, it could also be observed that it was not more toxic
to mammalian cells than the standard drug, resulting in a similar
CC50 value. Considering the clinical importance of the intracellular
amastigotes, additional studies were performed using macro-
phages as host mammalian cells. Gibbilimbol B was effective in
eliminating amastigotes with an EC50 of 22.06 lg/mL, which was
similar to that observed for the standard drug glucantime (EC50
of 21 lg/mL) (Table 1).
The possible action of gibbilimbol B on Leishmania membranes
was studied using the ﬂuorescent probe SYTOX Green (Fig. 2). Gib-
bilimbol B exposure led to a gradual increase in SYTOX Green per-
meability, with the increase in ﬂuorescence beginning at 30 min to
a maximal intensity at 150 min. SYTOX Green (Molecular Probes)
is a high-afﬁnity nucleic acid stain that penetrates cells with com-
promised plasma membranes and enhances its ﬂuorescence by
more than 500-fold upon nucleic acid binding. The non-ionic
surfactant Triton X-100 was used as the positive control, resulting
in the maximal intensity of ﬂuorescence. Thus, increased plasma
membrane permeability in the early minutes of incubation with
gibbilimbol B could be ascribed to the disruption of the plasma
membrane of Leishmania, leading to the leakage of ions and cellular
death. Another compound in clinical use for leishmaniasis (ampho-
tericin B) has been shown to induce pore formation in the plasma
membrane of Leishmania, especially due to its high afﬁnity for
ergosterol (Saha et al., 1986; Olliaro and Bryceson, 1993; Urbina,
1997). Further studies with gibbilimbol B should be performed to
Table 1
Antiparasitic (anti-leishmanial and anti-trypanosomal) and cytotoxic effects of 4-
[(30E)-decenyl]phenol (gibbilimbol B) and standard drugs.
Cell EC50 lg/mL (95% CI)
Gibbilimbol B Standard drugs
L. (L.) infantum chagasi
promastigotes
23.32 (19.20–
28.31)
0.137a (0.071–0.254)
L. (L.) infantum chagasi
amastigotes
22.06 (17.01–
28.62)
21.01b (20.34–24.37)
T. cruzi trypomastigotes 17.49 (14.49–
21.12)
187.5c (129.9–273.8)
Cytotoxicity (NCTC cells) 59.04 (50.64–
68.84)
59.33a (41.93–67.55)
>100b
124.13c (111.08–
128.25)
EC50 – 50% effective concentration; 95 CI – 95% conﬁdence interval; nd – not
determined.
a Amphotericin B.
b Glucantime.
c Benznidazole.
Fig. 2. Effect of gibbilimbol B on the membrane of Leishmania promastigotes using
the ﬂuorescent probe SYTOX Green. Promastigotes of the control group were
treated with 0.5% MeOH. Fluorescence was measured in a microplate reader with
excitation and emission wavelengths of 485 and 520 nm, respectively.
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24-ergosterol in Leishmania.
This is the ﬁrst report describing the anti-protozoan activity
of gibbilimbol B. Gibbilimbols A–D were isolated from Piper
gibbilimbum (Piperaceae), demonstrating anti-bacterial activity
against Staphylococcus epidermidis and Bacillus cereus (Orjala
et al., 1998). In our assays, gibbilimbol B showed promising anti-
trypanosomal activity, with an EC50 of 17.49 lg/mL, which was
about 10-fold more effective than the standard drug benznidazole
(EC50 of 187 lg/mL). By the MTT assay and light microscopy, it was
also possible to conﬁrm its trypanocidal activity (Table 1).
In order to study the possible cytotoxicity of gibbilimbol B,
NCTC cells were incubated for 48 h, resulting in a CC50 value of
59.04 lg/mL. According to its anti-parasitic activity, the selectivity
index (EC50 parasite/CC50 mammalian cells) was calculated and re-
sulted in 3.3 for T. cruzi and 2.7 for Leishmania. Despite the toxicity
against the NCTC cells, no hemolytic activity could be detected for
gibbilimbol B at 75 lg/mL.4. Conclusion
The alkenylphenol gibbilimbol B was tested in vitro against
Leishmania spp. promastigotes and amastigotes and Trypanosomacruzi trypomastigotes. These in vitro assays demonstrated for the
ﬁrst time that Leishmania (L.) infantum chagasi and Trypanosoma
cruzi trypomastigotes are susceptible to gibbilimbol B. The
straightforward synthesis of gibbilimbols A–D reported in the liter-
ature (Abe et al., 2001; Vyvyan et al., 2002) associated with the no-
vel anti-protozoal activity of gibbilimbol B suggests that this
compound could be used as a novel prototype for further drug de-
sign studies for neglected diseases such as Chagas disease and
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